Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II/III Pharmacokinetic and Outcome Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B

NCT00768287 is registered in ClinicalTrials.gov with Medexus Pharma, Inc. as lead sponsor.

NCT NCT00768287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00768287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II/III Pharmacokinetic and Outcome Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B
Lead sponsor
Medexus Pharma, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2009
Completion date
December 31, 2016
Enrollment
77 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia b